• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Carriers with excessively low factor VIII procoagulant activity (VIII AHF): a study of two unrelated families with mild hemophilia A.

作者信息

Eyster M E, Ladda R L, Bowman H S

出版信息

Blood. 1977 Apr;49(4):607-18.

PMID:843619
Abstract

Two unrelated families are described with mild hemophilia A in whom six obligate carriers had unusually low VIII AHF levels. In each family, successive generations of males were affected with hemophilia A as determined by low VIII AHF in the presence of normal VIII AGN and VIII VWF levels. In the first family, two of five obligate carriers had low VIII AHF levels associated with clinical bleeding and one other had a history of bleeding. While receiving oral contraceptives, one of these two carriers was found to have a normal VIII AHF level. In the second family, four cousins below age 10 who were obligate carriers had significantly low VIII AHF levels, while a paternal aunt and paternal grandmother who were also obligate carriers had VIII AHF levels within the normal range. Hemorrhagic diathesis in multiple obligate carriers in these families is not readily explained by the Lyon hypothesis, and suggests that these families may be exmaples of an unusual allelic form of hemophilia A or that they may be transmitting several independent genes affecting VIII AHF levels. Our experience suggests that VIII AHF levels should be determined on all obligate or possible carriers prior to surgery to identify those individuals at risk for postoperative bleeding. Furthermore, it is suggested that hormonal therapy might be effective in the management of carriers with low levels of VIII AHF and clinical bleeding.

摘要

相似文献

1
Carriers with excessively low factor VIII procoagulant activity (VIII AHF): a study of two unrelated families with mild hemophilia A.
Blood. 1977 Apr;49(4):607-18.
2
Carrier detection in classic hemophilia by combined measurement of immunologic (VIII AGN) and procoagulant (VIII AHF) activities.
Am J Clin Pathol. 1976 Jun;65(6):975-81. doi: 10.1093/ajcp/65.6.975.
3
Sources of variability in antihemophilic factor (factor VIII) procoagulant titers and precipitating antigen levels among obligate carriers of classic hemophilia.典型血友病携带者中抗血友病因子(凝血因子VIII)促凝滴度和沉淀抗原水平的变异性来源。
Blood. 1981 May;57(5):928-32.
4
Absence of VIII AHF response to adrenalin in hemophilia A.
Am J Hematol. 1977;3:193-8. doi: 10.1002/ajh.2830030211.
5
Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.对血管性血友病中缺乏的、血小板聚集所必需的一种血浆因子进行定量测定。与凝血因子VIII促凝活性及抗原含量的关系。
J Clin Invest. 1973 Nov;52(11):2708-16. doi: 10.1172/JCI107465.
6
Heckathorn's disease: variable functional dificiency of antihemophilic factor (factor VIII).赫克索恩病:抗血友病因子(因子VIII)功能可变缺乏症。
Blood. 1975 Aug;46(2):161-73.
7
The laboratory diagnosis of the carrier state for classic hemophilia.经典血友病携带者状态的实验室诊断
Ann Intern Med. 1977 May;86(5):521-8. doi: 10.7326/0003-4819-86-5-521.
8
Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.血管性血友病因子对血浆中凝血因子VIII的稳定作用。关于输血后及解离的凝血因子VIII的研究以及血管性血友病患者的研究。
J Clin Invest. 1977 Aug;60(2):390-404. doi: 10.1172/JCI108788.
9
Carriers and noncarriers of haemophilia A: I. Multivariate analysis of pedigree data, screening blood coagulation tests and factor VIII variables.甲型血友病携带者与非携带者:I. 系谱数据、凝血筛查试验及凝血因子VIII变量的多变量分析
Thromb Res. 1982 Mar 1;25(5):401-14. doi: 10.1016/0049-3848(82)90130-x.
10
Relationship of factor VIII-like antigen (VIII AGN) and clot promoting acitivty (VIII AHF) as measured by one- and two-stage assays in patients with liver disease.
Br J Haematol. 1976 Dec;34(4):655-61. doi: 10.1111/j.1365-2141.1976.tb03612.x.

引用本文的文献

1
Clinical pharmacokinetics of factor VIII in patients with classic haemophilia.
Clin Pharmacokinet. 1987 Dec;13(6):365-80. doi: 10.2165/00003088-198713060-00002.
2
The female carrier of haemophilia--a problem for the anaesthetist.
Can Anaesth Soc J. 1978 Jul;25(4):266-9. doi: 10.1007/BF03005646.